Elanco Animal Health (ELAN) reported Q4 adjusted earnings Tuesday of $0.14 per diluted share, up from $0.08 a year earlier.

Analysts polled by FactSet expected $0.15.

Revenue for the quarter ended Dec. 31 was $1.02 billion, down from $1.04 billion a year earlier.

Analysts surveyed by FactSet expected $1.01 billion.

The company said it expects full-year 2025 adjusted earnings of $0.80 to $0.86 per share on revenue of $4.45 billion to $4.51 billion.

Analysts polled by FactSet expect adjusted earnings of $0.89 per share on $4.52 billion in revenue.

Elanco shares were 1% lower in premarket trading.